Anti-Tumor CAS 41575-94-4 Carboplatin Powder Carboplatin

• Customization: Available
• CAS No.: 41575-94-4
• Formula: C6h12n2o4PT
• Model NO.: QS-carboplatin
• EINECS: 255-446-0
• Packaging Material: Metal
• Storage Method: Normal
• Shelf Life: >12 Months
• Nutrient Composition: Carboplatin
• Resource: Carboplatin
• The content of active substances: >99%
• Product Name: Carboplatin
• Name: Carboplatin Powder
• Appearance: White Powder
• Grade: Pharmaceutical Grade
• Assay: 99%
• Test Method: HPLC
• Specific: COA
• Melting Point: 228-230ºC
• Boiling Point: 366.4ºC
• Mf: C6h12n2o4PT
• Mv: 371.248
• Density: 10.2
• pH: 5.5-7.5
• Colour: White
• Addition: 189.6ºC
• Transport Package: Negotiable
• Specification: Negotiable
• Trademark: QS-carboplatin
• Origin: Shaanxi Xi′ an
• Production Capacity: 100kg/Month

Product Description

Anti-Tumor CAS 41575-94-4 carboplatin Powder carboplatin

Product Description

Product Details

Product Name	Carboplatin
Appearance	White Powder
CAS No.	41575-94-4
MF	C6h12n2o4PT
MW	371.248

There are three differences in pharmacokinetics between carboplatin and cisplatin: firstly, the serum protein binding rate of carboplatin is only 24%, while cisplatin is above 90%; The second is the half-life of non bound platinum that can be ultrafiltration. Carboplatin has a half-life of 6 hours, while cisplatin has a short half-life and rapidly decreases in blood concentration. The third is urine excretion, with a daily urine excretion of 6.5% for carboplatin and 16% to 35% for cisplatin. Therefore, there is a significant difference in liver toxicity between the two.

Application&Function

Mainly used for small cell lung cancer, ovarian cancer, testicular tumors, head and neck squamous cell carcinoma, etc. The remission rate of small cell lung cancer with this product alone is 60%; The overall response rate of combined treatment with Vp-16 and IFO was 78%; The response rates of ovarian epithelial cancer and head and neck squamous cell carcinoma treated with monotherapy were 65% and 29%, respectively.
2. It can be used for non-small cell lung cancer, bladder cancer, cervical cancer, pleural mesothelioma, melanoma and endometrial cancer.
3. It can also be used for digestive system tumors, liver cancer, and radiation enhanced therapy.

Specification